Medication adherence issues in patients treated for COPD

Ruben D. Restrepo, Melissa T. Alvarez, Leonard D. Wittnebel, Helen Sorenson, Richard Wettstein, David L. Vines, Jennifer Sikkema-Ortiz, Donna D. Gardner, Robert L. Wilkins

Producción científica: Review articlerevisión exhaustiva

327 Citas (Scopus)


Although medical treatment of COPD has advanced, nonadherence to medication regimens poses a significant barrier to optimal management. Underuse, overuse, and improper use continue to be the most common causes of poor adherence to therapy. An average of 40%-60% of patients with COPD adheres to the prescribed regimen and only 1 out of 10 patients with a metered dose inhaler performs all essential steps correctly. Adherence to therapy is multifactorial and involves both the patient and the primary care provider. The effect of patient instruction on inhaler adherence and rescue medication utilization in patients with COPD does not seem to parallel the good results reported in patients with asthma. While use of a combined inhaler may facilitate adherence to medications and improve efficacy, pharmacoeconomic factors may influence patient's selection of both the device and the regimen. Patient's health beliefs, experiences, and behaviors play a significant role in adherence to pharmacological therapy. This manuscript reviews important aspects associated with medication adherence in patients with COPD and identifies some predictors of poor adherence.

Idioma originalEnglish (US)
Páginas (desde-hasta)371-384
Número de páginas14
PublicaciónInternational Journal of COPD
EstadoPublished - 2008

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Health Policy
  • Public Health, Environmental and Occupational Health


Profundice en los temas de investigación de 'Medication adherence issues in patients treated for COPD'. En conjunto forman una huella única.

Citar esto